We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information on narcolepsy and the pandemic flu vaccine.
IFF Research have been commissioned to conduct a qualitative study to explore attitudes to COVID-19 vaccines and vaccination roll-out among groups who refuse, are unsure about, or experience barriers to accessing the vaccine.
Information for healthcare professionals and the public about Spikevax
The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 13 September 2021
A childhood varicella (chickenpox) vaccine would be offered in 2 doses, at 12 and 18 months of age.
UK Chief Medical Officers' and lead Deputy Chief Medical Officers for vaccines' opinion on the 15-minute wait after vaccination with mRNA vaccine for COVID-19.
Influenza vaccines marketed in the UK for 2024 to 2025, including ovalbumin content.
Information for eligible adults on COVID-19 vaccination.
Information on the smallpox vaccination used to protect you against the monkeypox virus (MPXV).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).